Ipsen Quote - IPN

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

118.80

Bid

118.50

Ask

119.40

Volume

150,260

115.20 Day's Range 119.50

99.70 52 Week Range 126.70

Market Cap

9.745B

Previous Close

118.50

Open

118.20

Last Trade

118.8

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

63,246

Shares Outstanding

82,029,421

Dividend Yield

1.01%

PE Ratio

15.12

Earnings Per Share (EPS)

7.86

Revenue

3.37B

Net Profit

644.4M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ipsen.com

Headquarters

Boulogne-billancourt, Hauts-de-seine, Fra

Founded

Ipsen SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker IPN. The last closing price for Ipsen was 118.50 €. Over the last year, Ipsen shares have traded in a share price range of 99.70 € to 126.70 €.

Ipsen currently has 82,029,421 shares outstanding. The market capitalization of Ipsen is 9.72 € billion. Ipsen has a price to earnings ratio (PE ratio) of 15.12.

Ipsen - Décembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Décembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de...

Ipsen - Bilan semestriel - 31 12 2024

Ipsen - Bilan semestriel - 31 12 2024 Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF Boulogne-Billancourt (France), le 7 janvier 2025 - Au titre du contrat de liquidité...

Ipsen - December 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - December 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights...

Ipsen - Half year statement - 2024 12 31

Ipsen - Half year statement - 2024 12 31 Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF Boulogne-Billancourt (France), January 7th, 2025 – Under the liquidity agreement...

Ipsen - Novembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Novembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de...

Ipsen - November 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - November 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights...

Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology

Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology Ipsen secures exclusive global rights to develop, manufacture and...

Ipsen et Biomunex annoncent un accord de licence mondial exclusif pour un activateur de cellules MAIT, une nouvelle classe thérapeutique en immuno-oncologie

Ipsen et Biomunex annoncent un accord de licence mondial exclusif pour un activateur de cellules MAIT, une nouvelle classe thérapeutique en immuno-oncologie Ipsen obtient les droits mondiaux...

Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology

Ipsen secures exclusive global rights to develop, manufacture and commercialize BMX-502, a pre-clinical novel T cell engager (TCE) with first-in-class potentialBMX-502 is a bispecific antibody...

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS Ipsen presents 3 late-breaking presentations and 8 abstracts across...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1	0.0842459983151	118.7	121.9	115.2	61141	119.3722901	DE
4	7.8	7.02702702703	111	125.6	111	62825	119.4507267	DE
12	9.3	8.49315068493	109.5	125.6	105.3	63246	112.78179374	DE
26	16	15.5642023346	102.8	125.6	100.3	61663	111.01139833	DE
52	10.8	10	108	126.7	99.7	69133	111.19573489	DE
156	32.66	37.9150220571	86.14	130.7	80	78682	106.10630282	DE
260	51.9	77.5784753363	66.9	130.7	34.2	97685	90.14393322	DE

IPN - Frequently Asked Questions (FAQ)

What is the current Ipsen share price?

The current share price of Ipsen is 118.80 €

How many Ipsen shares are in issue?

Ipsen has 82,029,421 shares in issue

What is the market cap of Ipsen?

The market capitalisation of Ipsen is EUR 9.72B

What is the 1 year trading range for Ipsen share price?

Ipsen has traded in the range of 99.70 € to 126.70 € during the past year

What is the PE ratio of Ipsen?

The price to earnings ratio of Ipsen is 15.12

What is the cash to sales ratio of Ipsen?

The cash to sales ratio of Ipsen is 2.89

What is the reporting currency for Ipsen?

Ipsen reports financial results in EUR

What is the latest annual turnover for Ipsen?

The latest annual turnover of Ipsen is EUR 3.37B

What is the latest annual profit for Ipsen?

The latest annual profit of Ipsen is EUR 644.4M

What is the registered address of Ipsen?

The registered address for Ipsen is 65 QUAI GEORGES GORSE, BOULOGNE-BILLANCOURT, HAUTS-DE-SEINE, 92100

What is the Ipsen website address?

The website address for Ipsen is www.ipsen.com

Which industry sector does Ipsen operate in?

Ipsen operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BIODSBiosynex DS	0.0502 € (80.58%)	96.34k
ALTROTronic s Microsystems	5.30 € (35.20%)	5
MLWEYWeya	0.027 € (35.00%)	99k
VACBSPierre & Vacances	0.0708 € (24.21%)	46.14k
MCPGrupo Media Capital Sgps Sa	2.00 € (23.46%)	1,000
MLGEQGentlemen S Equity SA	0.0115 € (-47.73%)	6.2k
NICBSNicox SA	0.0183 € (-30.68%)	140
AELISAelis Farma SA	3.76 € (-21.67%)	33.01k
ALNEVNeovacs	0.32 € (-17.40%)	21.49k
ALBOOBOOSTHEAT	0.035 € (-16.27%)	43.42k
ATOAtos SE	0.0022 € (4.76%)	1.58B
BCPBanco Comercial Portugues SA	0.5052 € (-0.67%)	50M
ALNRGEnergisme SA	0.0041 € (-6.82%)	29.28M
KPNKoninklijke KPN NV	3.554 € (-1.88%)	12.28M
ALCYBCybergun	0.0001 € (0.00%)	9.42M